Ulrich Patzak

Title: Ulrich Patzak: Innovator in Pharmaceutical Compositions

Introduction

Ulrich Patzak is a notable inventor based in Leiderdorp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms for various medical conditions. With a total of 2 patents to his name, his work has the potential to impact the treatment of several types of cancer.

Latest Patents

Patzak's latest patents include innovative pharmaceutical compositions that enhance the oral administration of bendamustine. The first patent focuses on solid dosage forms of bendamustine, which includes a composition suitable for oral administration. This composition comprises bendamustine or its pharmaceutically acceptable derivatives, combined with a saccharide excipient. The specific weight ratio of the active ingredient to the excipient is maintained between 1:1 and 5.

The second patent details oral dosage forms of bendamustine that demonstrate a dissolution rate of at least 60% in 20 minutes, 70% in 40 minutes, and 80% in 60 minutes. This is measured using a paddle apparatus in a dissolution medium at a pH of 1.5. The invention is aimed at treating various medical conditions, including chronic lymphocytic leukemia, acute lymphocytic leukemia, and several types of cancer such as breast and lung cancer.

Career Highlights

Throughout his career, Ulrich Patzak has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Astellas Deutschland GmbH and Pharma & Schweiz GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Patzak has collaborated with several professionals in his field, including Taoufik Ouatas and Jeffrey Colledge. These collaborations have likely enriched his research and development efforts, leading to his successful patent applications.

Conclusion

Ulrich Patzak is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve treatment options for various cancers. His innovative patents reflect his commitment to advancing medical science and enhancing patient care.